🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 6 week study to assess the effect of BI 671800 in patients with a...
Status
Completed
Location
1268.16.01004 Boehringer Ingelheim Investigational Site
Start Date
2010-04-20
Trial ID
NCT01103349
Treatments Being Tested
The investigators aimed to prospectively investigate the effects of esomepr...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-01
Trial ID
NCT03598738
Treatments Being Tested
Oxidative stress has been investigated as a key factor in the pathogenesis ...
Status
Unknown
Location
Royan Institute
Start Date
2021-04-13
Trial ID
NCT05460858
Treatments Being Tested
Clinical Trial to evaluate the pharmacokinetic Characteristics, safety and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07532148
Eustachian tube dysfunction is distressing probelm. drugs usually are not e...
Status
Recruiting
Location
Cairo University
Start Date
2025-05-12
Trial ID
NCT07193485
Treatments Being Tested
Much has been learned about the efficacy and effectiveness of comprehensive...
Status
Unknown
Location
South Texas Rural Health Services Clinic
Start Date
2017-11-01
Trial ID
NCT03186885
To evaluate whether daily oral micronized progesterone is effective in prev...
Status
Completed
Location
Miami Valley HospitaL
Start Date
2006-11
Trial ID
NCT01180296
Treatments Being Tested
SPH3127 tablet is a of renin inhibitor. It is expected to be a new drug for...
Status
Completed
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2019-01-11
Trial ID
NCT03756103
Treatments Being Tested
This study evaluates the effect of ecopipam tablets in children and adolesc...
Status
Completed
Location
Harmonex Neuroscience Research
Start Date
2019-06-28
Trial ID
NCT04007991
Upadacitinib sustained-release tablets have not yet been approved for the t...
Status
Active Not Recruiting
Location
Tianjin Eye hospital
Start Date
2025-01-01
Trial ID
NCT07773623
Treatments Being Tested